002644SZSE

Foci Pharmaceutical Co., Ltd.

佛慈制药

002644

Shenzhen Stock Exchange

Follow
30 announcements tracked· Last: May 12, 2026

Key Financials

Revenue¥211.6M
Net Profit¥22.7M
ROE1.23%
Debt Ratio27.11%
Monetary Funds¥565.2M
Receivables¥323.6M
Goodwill¥9.0M
Total Shares510.7M

Announcements

30 total

Compensation Management System for Directors and Senior Management (May 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notice of the 2026 Second Extraordinary Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement of Resolutions from the Sixteenth Meeting of the Eighth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Legal Opinion from Gansu Jincheng Law Firm on the 2025 Annual Shareholders' Meeting of Lanzhou Foci Pharmaceutical Co., Ltd.

Share PledgeShareholding Change DisclosureListed Company Announcements

Announcement of the Resolutions of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement of the Resolution of the 15th Meeting of the Eighth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Q1 2026 Report

Share Repurchase CompletionShareholding Change DisclosurePeriodic Financial Reports

Announcement on the Online Performance Briefing for the 2025 Annual Report and the First Quarter of 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Legal Opinion from Gansu Jincheng Law Firm on the First Extraordinary Shareholders' Meeting of Lanzhou Foci Pharmaceutical Co., Ltd. in 2026

Share PledgeShareholding Change DisclosureListed Company Announcements

Announcement on the Resolutions of the First Extraordinary Shareholders' Meeting of 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Report Summary

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureAnnual Report

Independent Director 2025 Annual Work Report (Jia Hongwen)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director 2025 Annual Work Report (Li Zhigang)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Independent Director 2025 Annual Work Report (Hu Huayun)

Convertible BondsShareholding Change DisclosureListed Company Announcements

Internal Control Audit Report

Share PledgeShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Financial Responsible Person Management System (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Board Major Issues Compliance Review System (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Board Resolution Tracking Implementation and Post-Evaluation System (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Emergency response system for sudden incidents (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Detailed rules for the work of the board secretary (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Director and senior management compensation management system (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

External guarantee management system (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Related party transaction management system (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

System for preventing the occupation of funds by the controlling shareholder or actual controller and their related parties (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Fundraising management system (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Audit committee annual report work system (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Management rules for the management team (April 2026)

Share Repurchase PlanShareholding Change DisclosureListed Company Announcements

2025 annual board of directors work report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notes & Comments

Sign in to leave a comment or private note.

Loading…